Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
J Med Chem ; 39(5): 1172-88, 1996 Mar 01.
Artigo em Inglês | MEDLINE | ID: mdl-8676355

RESUMO

A series of substituted (4-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)butyl)benzamide derivatives was prepared and evaluated as potential atypical antipsychotic agents. The target compounds were readily prepared from their benzoyl chloride, benzoic acid, or isatoic anhydride precursors, and they were evaluated in vitro for their ability to bind to dopamine D2, serotonin 5-HT2, and serotonin 5-HT1a receptors. To assess the potential antipsychotic activity of these compounds, we investigated their ability to inhibit the apomorphine-induced climbing response in mice. Selected compounds were evaluated further to determine their side-effect potentials. Structure-activity relationships of both mono- and polysubstituted benzamides are discussed herein. While several analogues had potent in vitro and in vivo activities indicative of potential atypical antipsychotic activity, anthranilamide 77 (1192U90) ddemonstrated a superior pharmacological profile. As a result of this investigation, 1192U90 (2-amino-N-(4-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)butyl)ben zamide hydrochloride) was selected for further evaluation and is currently in phase I clinical trials as a potential atypical antipsychotic agent.


Assuntos
Antipsicóticos/síntese química , Piperazinas/síntese química , Receptores de Dopamina D2/metabolismo , Receptores de Serotonina/metabolismo , Agonistas do Receptor de Serotonina/síntese química , Tiazóis/síntese química , Animais , Antipsicóticos/metabolismo , Antipsicóticos/farmacologia , Apomorfina/farmacologia , Camundongos , Estrutura Molecular , Atividade Motora/efeitos dos fármacos , Piperazinas/metabolismo , Piperazinas/farmacologia , Agonistas do Receptor de Serotonina/metabolismo , Agonistas do Receptor de Serotonina/farmacologia , Relação Estrutura-Atividade , Tiazóis/metabolismo , Tiazóis/farmacologia
2.
J Med Chem ; 36(16): 2279-91, 1993 Aug 06.
Artigo em Inglês | MEDLINE | ID: mdl-8360872

RESUMO

The synthesis and thymidylate synthase (TS) inhibitory activity of a series of simple benzo[f]-quinazolin-1(2H)-ones are described. Fully aromatic 3-amino compounds with compact lipophilic substituents in the 9-position were found to have I50 values as low as 20 nM on the isolated enzyme, and represent the first examples of potent, folate-based TS inhibitors that completely lack any structural feature corresponding to the (p-aminobenzoyl)glutamate moiety of the cofactor. A number of the compounds also showed moderate growth inhibitory activity against a human colon adenocarcinoma cell line (SW480), with IC50 values as low as 2 microM.


Assuntos
Quinazolinas/síntese química , Quinazolinas/farmacologia , Timidilato Sintase/antagonistas & inibidores , Adenocarcinoma/patologia , Divisão Celular/efeitos dos fármacos , Neoplasias do Colo/patologia , Escherichia coli/enzimologia , Humanos , Relação Estrutura-Atividade , Células Tumorais Cultivadas
3.
J Med Chem ; 27(6): 717-26, 1984 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-6429331

RESUMO

Arabinose 5-phosphate ( A5P ) isomerase is a key enzyme in the biosynthesis of lipopolysaccharide, an essential component of the outer membrane of Gram-negative bacteria. The mechanism of the isomerase is envisioned to involve an enediol intermediate. A series of compounds, which are analogues of the substrates or intermediate, were tested as inhibitors of A5P isomerase with the belief that a good inhibitor would stop bacterial growth or render the cells more susceptible to other antibiotics or natural defenses. In a series of phosphorylated sugars, the order of isomerase inhibitory activity was as follows: aldonic acids greater than alditols greater than aldoses. Nonphosphorylated sugars were much less inhibitory. The best inhibitor was erythronic acid 4-phosphate (54), which had Km/Ki = 29. None of the compounds displayed antibacterial activity in vitro.


Assuntos
Aldose-Cetose Isomerases , Bactérias/enzimologia , Carboidratos Epimerases/antagonistas & inibidores , Lipopolissacarídeos/biossíntese , Arabinose/análogos & derivados , Cinética , Lactonas/farmacologia , Ribose/análogos & derivados , Ribose/farmacologia , Açúcares Ácidos/farmacologia , Fosfatos Açúcares/farmacologia
4.
Ann Surg ; 198(3): 370-8, 1983 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-6351775

RESUMO

Transplantation between non-identical humans has been limited by the requirement for chronic immunosuppression (CI). This study demonstrates in a nonhuman primate model that long-term acceptance of incompatible kidney allografts can be achieved without the use of CI. Following incompatible kidney transplantation, rhesus monkey recipients were given a 5-day course of clinical rabbit antithymocyte globulin (RATG). On day 12, unfractionated donor bone marrow (BM) was infused intravenously. Recipients were monitored for T-cell levels and T-cell subset levels with monoclonal antibodies and for responses in one way MLR. Graft survival in untreated control animals was 9.2 +/- 2.8 days. In six animals given RATG only, all died of rejection at a mean 35.8 +/- 5.7 days. Of five animals given RATG and donor BM (mean 2.5 RhLA mismatches, mean MLC 12.7), four are alive at 150 days, 248 days, 342 days, and 401 days (median 248 days). The ATG-BM infused group showed a prolonged imbalance of their OKT4/OKT8 cell ratio and cellular suppression of MLR responsiveness. The long-term survival obtained in these outbred primates is apparently due to a synergistic immunoregulatory effect induced by the RATG and donor BM. The model described is apparently the first report of long-term survival of outbred higher primates without CI and may represent a technique for producing tolerance without CI in the human.


Assuntos
Sobrevivência de Enxerto , Transplante de Rim , Macaca mulatta , Macaca , Modelos Biológicos , Animais , Transplante de Medula Óssea , Creatinina/sangue , Teste de Histocompatibilidade , Imunossupressores , Interleucina-2/administração & dosagem , Rim/patologia , Masculino , Linfócitos T/análise
5.
Surgery ; 94(2): 384-91, 1983 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-6224306

RESUMO

The mechanism responsible for the profound and enduring immunosuppressive action of antithymocyte globulin (ATG) is not well understood. In a primate model, we found that a 5-day rabbit ATG (RATG treatment course activates a prostaglandin (PG)-dependent suppressor cell mechanism that persists for several months. Groups of normal rhesus monkey skin allograft recipients, kidney allograft recipients, or nontransplant control animals received either RATG or no immunosuppression. The peripheral blood mononuclear cell (PBMC) population was longitudinally monitored for (1) percentage of total T cells, helper cells, and suppressor/cytotoxic T cell subsets with the monoclonal antibodies Leu-5, OKT4, and CKT8, respectively, and (2) phytohemagglutinin (PHA)-induced lymphocyte proliferative responses (LPR). The nonimmunosuppressed control groups showed no significant changes in any of these parameters. In contrast, PBMCs from all RATG-treated monkeys developed a persistent imbalance in the ratio of OKT4+ and OKT8+ subsets. Their PBMCs became unresponsive to PHA and remained unresponsive (less than 20% of control level) for at least 3 months, although total T cell counts recovered within 2 to 3 weeks after cessation of RATG. Addition of PG synthetase inhibitors indomethacin. RO-20-5720, and tolmetin caused a significant, dose-dependent recovery of LPR that was completely inhibited by exogenous PGE2 at 1 X 10(-8) M. PBMCs from RATG-treated monkeys caused a dose-dependent suppression of the normal PHA response, and this suppressor cell activity was blocked by indomethacin. PHA responses of nonimmunosuppressed control groups were not increased significantly in the presence of PG synthetase inhibitors, were less sensitive to suppression by PGE2, and did not exhibit suppressor cell activity. These data suggest that the prolonged depression in LPR after RATG treatment is due to an active PG-dependent suppressor cell mechanism and provide a new concept to explain the immunosuppressive action of RATG.


Assuntos
Soro Antilinfocitário/farmacologia , Tolerância Imunológica/efeitos dos fármacos , Prostaglandinas/farmacologia , Linfócitos T/imunologia , Animais , Anticorpos Monoclonais/análise , Relação Dose-Resposta a Droga , Transplante de Rim , Ativação Linfocitária , Macaca mulatta , Masculino , Modelos Biológicos , Coelhos , Transplante de Pele , Linfócitos T/análise , Linfócitos T Reguladores/análise , Fatores de Tempo , Transplante Autólogo
7.
J Med Chem ; 24(6): 753-6, 1981 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-6265637

RESUMO

A number of pyrimidine acyclic nucleosides were synthesized and tested for activity against herpes simplex virus type 1. Synthesis of 1-[(2-hydroxyethoxy)methyl]cytosine (8) and 1-[(2-hydroxyethoxy)methyl]uracil (14) was accomplished in two or three steps from 2,4-diethoxypyrimidine and 2-(benzoyloxy)ethoxymethyl chloride. The 5-methyl (20), 5-(trifluoromethyl) (21), and 5-fluoro (22) analogues of 14 were available in two steps form the appropriate bis(trimethylsilyl)ated 5-substituted uracil and 2-(acetoxymethoxy)ethyl acetate or 2-(benzoyloxy)ethoxymethyl chloride. Bromination of 8 and 14 or iodination of 14 gave the 5-halogeno-1-[(2-hydroxyethoxy)methyl]pyrimidines 9, 23, and 24. These pyrimidine acyclic nucleosides exhibited little or no activity against herpes simplex virus type 1 or against a range of other DNA and RNA viruses. This is compatible with their lack of substrate properties toward herpes simplex virus induced thymidine kinase.


Assuntos
Antivirais , Nucleosídeos de Pirimidina/farmacologia , Simplexvirus/efeitos dos fármacos , Aciclovir , Animais , Vírus de DNA/efeitos dos fármacos , Guanina/análogos & derivados , Guanina/síntese química , Guanina/farmacologia , Camundongos , Nucleosídeos de Pirimidina/síntese química , Vírus de RNA/efeitos dos fármacos , Uracila/análogos & derivados , Uracila/síntese química , Uracila/farmacologia
8.
J Med Chem ; 20(2): 275-9, 1977 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-836499

RESUMO

By means of a molecular orbital method which considers all valence electrons, INDO, we have calculated several electronic indices and determined the major tautomers in the lactan-lactim tautomerism of alloxan in the liquid and gaseous states. We have found that the principal tautomer, in both the gas phase and in solution, is the keto form; however, in solution, we have found a major contribution by the 2-hydroxy form. In addition, we have determined that the most reactive group, in all tautomers, to nucleophilic addition is the 5-CO group. We also made some observations concerning the effect of the electronic structure of alloxan on its diabetogenic activity.


Assuntos
Aloxano/farmacologia , Fenômenos Químicos , Química , Gases , Teoria Quântica , Soluções , Estereoisomerismo , Relação Estrutura-Atividade , Termodinâmica
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA